TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BWT Pharma & Biotech AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 29,864 | 19,858 | 20,302 |
Financial expenses | 4 | 4 | 1 |
Earnings before taxes | 4,335 | 2,385 | 175 |
EBITDA | 4,366 | 2,432 | 217 |
Total assets | 18,201 | 13,982 | 10,176 |
Current assets | 18,066 | 13,819 | 10,000 |
Current liabilities | 12,497 | 8,289 | 6,544 |
Equity capital | 4,782 | 3,447 | 1,598 |
- share capital | 45 | 49 | 50 |
Employees (average) | 42 | 37 | 28 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 26.3% | 24.7% | 15.7% |
Turnover per employee | 711 | 537 | 725 |
Profit as a percentage of turnover | 14.5% | 12.0% | 0.9% |
Return on assets (ROA) | 23.8% | 17.1% | 1.7% |
Current ratio | 144.6% | 166.7% | 152.8% |
Return on equity (ROE) | 90.7% | 69.2% | 11.0% |
Change turnover | 11,615 | -68 | 2,245 |
Change turnover % | 64% | 0% | 12% |
Chg. No. of employees | 5 | 9 | 5 |
Chg. No. of employees % | 14% | 32% | 22% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.